首页> 外文OA文献 >Initial medication adherence-review and recommendations for good practices in outcomes research: an ISPOR medication adherence and persistence special interest group report
【2h】

Initial medication adherence-review and recommendations for good practices in outcomes research: an ISPOR medication adherence and persistence special interest group report

机译:初始药物依从性-结局研究中良好实践的回顾和建议:ISPOR药物依从性和持久性特殊兴趣小组报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Positive associations between medication adherence and beneficial outcomes primarily come from studying filling/consumption behaviors after therapy initiation. Few studies have focused on what happens before initiation, the point from prescribing to dispensing of an initial prescription. Objective: Our objective was to provide guidance and encourage high-quality research on the relationship between beneficial outcomes and initial medication adherence (IMA), the rate initially prescribed medication is dispensed. Methods: Using generic adherence terms, an international research panel identified IMA publications from 1966 to 2014. Their data sources were classified as to whether the primary source reflected the perspective of a prescriber, patient, or pharmacist or a combined perspective. Terminology and methodological differences were documented among core (essential elements of presented and unpresented prescribing events and claimed and unclaimed dispensing events regardless of setting), supplemental (refined for accuracy), and contextual (setting-specific) design parameters. Recommendations were made to encourage and guide future research. Results: The 45 IMA studies identified used multiple terms for IMA and operationalized measurements differently. Primary data sources reflecting a prescriber\u27s and pharmacist\u27s perspective potentially misclassified core parameters more often with shorter/nonexistent pre- and postperiods (1-14 days) than did a combined perspective. Only a few studies addressed supplemental issues, and minimal contextual information was provided. Conclusions: General recommendations are to use IMA as the standard nomenclature, rigorously identify all data sources, and delineate all design parameters. Specific methodological recommendations include providing convincing evidence that initial prescribing and dispensing events are identified, supplemental parameters incorporating perspective and substitution biases are addressed, and contextual parameters are included.
机译:背景:药物依从性和有益结果之间的正相关性主要来自研究治疗开始后的填充/消耗行为。很少有研究集中在开始之前的事情上,即从开处方到分发初始处方的过程。目的:我们的目标是就有益结果与初始用药依从性(IMA)之间的关系提供指导并鼓励进行高质量的研究,该方法规定了最初用药的比例。方法:使用通用的依从性术语,一个国际研究小组确定了1966年至2014年的IMA出版物。对它们的数据来源进行了分类,以确定主要来源是否反映出处方者,患者或药剂师的观点或综合观点。在核心(已陈述和未陈述的处方事件以及要求和未主张的配药事件的基本要素,与设置无关),补充性(针对准确性进行了细化)和上下文(特定于设置)的设计参数之间记录了术语和方法上的差异。提出了鼓励和指导未来研究的建议。结果:进行的45项IMA研究确定了对IMA使用的多个术语以及可操作的度量值。反映开药者和药剂师观点的主要数据源与合并的观点相比,前期和后期较短(或不存在)(1-14天)的情况下,更经常错误地分类核心参数。只有少数研究解决了补充问题,并且提供的背景信息很少。结论:一般建议是使用IMA作为标准术语,严格识别所有数据源,并勾画所有设计参数。具体的方法学建议包括提供令人信服的证据,表明已识别出最初的处方和配药事件,解决了合并了观点和替代偏见的补充参数,并包括了上下文参数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号